Expression of inflammatory genes, WBC-derived inflammatory biomarkers and liver function indices: Effects of myo-inositol supplementation in obese patients with NAFLD-Reference-Cited by-同舟云学术

Expression of inflammatory genes, WBC-derived inflammatory biomarkers and liver function indices: Effects of myo-inositol supplementation in obese patients with NAFLD

Published:2023-05 Issue: Volume:104 Page:105524
ISSN:1756-4646
Container-title:Journal of Functional Foods
language:en
Short-container-title:Journal of Functional Foods

Author:

Arefhosseini Sara,Roshanravan Neda,Asghari Samira,Tutunchi Helda,Ebrahimi-Mameghani Mehrangiz

Funder

Tabriz University of Medical Sciences

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Medicine (miscellaneous),Food Science

Reference61 articles.

1. Liver steatosis is associated both with platelet distribution width, neutrophil/lymphocyte and monocyte/lymphocyte ratios;Aktas;Primary Health Care: Open Access,2020

2. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications;Alisi;Mediators of Inflammation,2017

3. Neutrophil to lymphocyte ratio: A new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease;Alkhouri;Liver International,2012

4. Protective effect of D-pinitol on the experimental spinal cord injury in rats;An;Metabolic Brain Disease,2020

5. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD;Angulo;Hepatology,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial;Cell Reports Medicine;2024-08

2. The effect of myo‐inositol supplementation on AMPK/PI3K/AKT pathway and insulin resistance in patients with NAFLD;Food Science & Nutrition;2024-07-16

3. Association of systemic inflammatory indices with anthropometric measures, metabolic factors, and liver function in non-alcoholic fatty liver disease;Scientific Reports;2024-06-04

4. Myo-inositol supplementation in obese patients with non-alcoholic fatty liver disease: Assessment of sirtuin-1 pathway, atherogenic and hematological parameters;Journal of Functional Foods;2024-05

5. Effects of inositols on adipokines: A systematic review of current knowledge and potential mechanisms;Journal of Functional Foods;2024-03